93 7456 (Glipizide and metformin hydrochloride 2.5 mg / 500 mg)

Pill imprint 93 7456 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 500 mg.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 7456

Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456 Front
Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456 Back
Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456
Glipizide and metformin hydrochloride
Imprint:
93
7456
Strength:
2.5 mg / 500 mg
Color:
White
Size:
17.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7456
Inactive Ingredients:
corn starch
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
povidone k30
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00555-0626 Barr Laboratories Inc
00591-3972 Watson Pharmaceuticals, Inc. (now Actavis, Inc)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)